Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants. Issue 2 (22nd July 2020)
- Record Type:
- Journal Article
- Title:
- Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants. Issue 2 (22nd July 2020)
- Main Title:
- Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants
- Authors:
- Adedoyin, Adedayo
Fancourt, Craig
Menzel, Karsten
Zhao, Tian
Tomek, Charles
Panebianco, Deborah
McCrea, Jacqueline B.
Stoch, S. Aubrey
Iwamoto, Marian - Abstract:
- Abstract: Letermovir is a prophylactic agent for cytomegalovirus infection and disease in adult cytomegalovirus‐seropositive recipients of allogeneic hematopoietic stem cell transplant. As the antifungal agent fluconazole is administered frequently in transplant recipients, a drug–drug interaction study was conducted between oral letermovir and oral fluconazole. A phase 1 open‐label, fixed‐sequence study was performed in healthy females (N = 14, 19‐55 years). In Period 1, a single dose of fluconazole 400 mg was administered. Following a 14‐day washout, a single dose of letermovir 480 mg was administered (Period 2), and after a 7‐day washout, single doses of fluconazole 400 mg and letermovir 480 mg were coadministered in Period 3. Pharmacokinetics and safety were evaluated. The pharmacokinetics of fluconazole and letermovir were not meaningfully changed following coadministration. Fluconazole geometric mean ratio (GMR; 90% confidence interval [CI]) with letermovir for area under the concentration‐versus‐time curve from time 0 to infinity (AUC0‐∞ ) was 1.03 (0.99‐1.08); maximum concentration (Cmax ) was 0.95 (0.92‐0.99). Letermovir AUC0‐∞ GMR (90%CI) was 1.11 (1.01‐1.23), and Cmax was 1.06 (0.93‐1.21) following coadministration with fluconazole. Coadministration of fluconazole and letermovir was generally well tolerated.
- Is Part Of:
- Clinical pharmacology in drug development. Volume 10:Issue 2(2021)
- Journal:
- Clinical pharmacology in drug development
- Issue:
- Volume 10:Issue 2(2021)
- Issue Display:
- Volume 10, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 10
- Issue:
- 2
- Issue Sort Value:
- 2021-0010-0002-0000
- Page Start:
- 198
- Page End:
- 206
- Publication Date:
- 2020-07-22
- Subjects:
- allogeneic hematopoietic stem cell transplant recipients -- cytomegalovirus -- drug–drug interaction -- fluconazole -- letermovir -- pharmacokinetics
Drugs -- Testing -- Periodicals
Drug development -- Periodicals
Clinical pharmacology -- Periodicals
615.580724 - Journal URLs:
- http://cpd.sagepub.com ↗
http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%292160-7648 ↗
http://accp1.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2160-7648/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cpdd.852 ↗
- Languages:
- English
- ISSNs:
- 2160-7648
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.330300
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 15568.xml